|
AstraZeneca plc, is a large Anglo-Swedish pharmaceutical company formed in April 1999 by the merger of Swedish Astra and British Zeneca. Zeneca was originally known as ICI Pharmaceuticals, before it was demerged in June 1993 from the British chemicals company, ICI.
Sales in 2003 totalled $18.8 billion, with a profit before tax of $4.2 billion. Total R&D spend was $3.5 billion. The corporate HQ is in London UK, the R&D HQ in Södertälje, Sweden. Key R&D centres are located in Alderley Park, near Macclesfield, UK, and Wilmington, Delaware, USA.
The current chief executive of AstraZeneca is Sir Tom McKillop.
Products
AstraZeneca specialises in prescription medicines to fight disease in the following therapeutic areas (with selected brand-name products and 2003 revenues).
Diversity
AstraZeneca is one of the 100 Best Companies for Working Mothers in 2004 according to Working Mothers magazine.
See also
External links
|